C3 and lung carcinoma: Supporting this, we were not able to detect expression of the complement component C3 in BCP‐ALL cells (data not shown), in contrast to leptomeningeal metastatic cells from breast and lung cancer that secrete C3 to activate C3a receptor in CP epithelial cells and disrupt the BCSFB, allowing molecules and cells to enter the CSF [30].